@MeToo I agree with you in terms of SP and the ups and downs in relevant time periods. Although saying this you can compare similarities between PYL, IGS and other emerging biotechs in terms of what they will be going through. A big interest (spike in sp) > boredom >share price teetering off > announcements > no talk > exciting announcement > SP jump 5-10%. Rinse and repeat it will be a long slog for all companies involved in this niche sector of the health market. I think you will find once legislation starts to slowly open up. I'm talking about import/export laws regarding CBD,THC,CBN etc. Once related businesses can freely trade between respective countries MGC markets, then we will see things really start to heat up. That will most likely (personal opinion) be 3-4 months away, close to sept, if not the start of oct.
Cheers,
Nuts
DYOR
IGS Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held